The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.

about

Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activation The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.

P2860

Q35089880-BC641ECB-03F3-47D0-9717-410182B2AF56 Q37169716-BD1EDBCC-B522-42FC-95A9-F854CFE98535

P2860

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.

Item

http://www.wikidata.org/entity/Q36909521

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The role of angiotensin II typ ...... nagement of diabetes mellitus.

@en

type

Item

label

The role of angiotensin II typ ...... nagement of diabetes mellitus.

@en

prefLabel

The role of angiotensin II typ ...... nagement of diabetes mellitus.

@en

P1476

The role of angiotensin II typ ...... nagement of diabetes mellitus.

@en

P2093

Davis G

http://www.w3.org/2001/XMLSchema#string

Mathur G

http://www.w3.org/2001/XMLSchema#string

Noronha B

http://www.w3.org/2001/XMLSchema#string

Rodrigues E

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

P304

617-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1463-1326.2006.00644.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17697055

http://www.w3.org/2001/XMLSchema#string

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.

about

P2860

P2860

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698